1. Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M, Iwanaga M, Miyazaki Y, Cullings HM, Suyama A, Ozasa K, Shore RE, Mabuchi K (2013) The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res 179(3):361–382
2. Gault N, Verbiest T, Badie C, Romeo PH, Bouffler S (2019) Hematopoietic stem and progenitor cell responses to low radiation doses - implications for leukemia risk. Int J Radiat Biol 95(7):892–899
3. Lukavetsky LM (1999) Leukemias and lymphomas morbidity in contaminated and uncontaminated by radionucleades areas caused by Chornobyl catastrophe. Thesis for a candidate’s degree of medical sciences. Kyiv: Research Institute of Hematology and Blood Transfusion, 19p (in Ukrainian)
4. Prisyazhniuk A, Gristchenko V, Zakordonets V, Fouzik N, Slipeniuk Y, Ryzhak I (1995) The time trends of cancer incidence in the most contaminated regions of the Ukraine before and after the Chernobyl accident. Radiat Environ Biophys 34(1):3–6
5. Fedorenko Z, Goulak L, Gorokh Ye, Ryzhov A, Soumkina O, Koutsenko L, eds. (2019) Cancer in Ukraine: incidence, mortality, activities of the oncological service. Available from: https://www.ncru.inf.ua/publications/. Accessed 14 July 2019